Templewater has successfully acquired TalkMED Group Limited, enhancing its Tamarind Health platform to address the growing oncology care demands in Asia.

Target Information

Templewater is pleased to announce that it has received the prestigious 'Deal of the Year (Mid Cap)' award at the AVCJ Private Equity & Venture Capital Awards 2025. This accolade recognizes Templewater's successful take-private of TalkMED Group Limited, orchestrated in collaboration with the leading doctors and management team from Tamarind Health. The transaction exemplifies Templewater's unique approach to control investing through identifying proprietary opportunities and facilitating complex, multi-jurisdictional processes encompassing due diligence, financing, and regulatory approvals.

The strategic integration of practices into a unified platform following the transaction is designed to enhance growth and operational efficiency. Tamarind Health currently operates a network of 36 outpatient and hospital-based centers across Singapore, Hong Kong, Malaysia, the Philippines, Vietnam, and Mainland China. This expansive network encompasses over 140 resident and visiting doctors and manages more than 180,000 patient visits annually. The platform includes notable entities such as OncoCare, TalkMED, Solis, Luma, Novena Heart Centre, Tamarind Specialists, and Can-Care.

Industry Overview

The healthcare industry in Southeast Asia, particularly in countries like Singapore, Hong Kong, Malaysia, and Vietnam, is experiencing remarkable transformation driven by increasing population demands, advancements in medical technology,